Sociodemographic determinants of cancer treatment health literacy

Ethnic and racial disparities in cancer outcomes are often attributed to sociodemographic factors, including income, education, insurance status, and access to quality cancer care. Less attention has been directed toward other possible contributors, such as misconceptions about cancer and its treatment.

[1]  R. Demicheli,et al.  Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases? , 2005, European journal of cancer.

[2]  R. Demicheli,et al.  Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour , 2004, Breast Cancer Research.

[3]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival , 2004, Cancer.

[4]  Angela Fagerlin,et al.  Patient Education Materials about the Treatment of Early-Stage Prostate Cancer: A Critical Review , 2004, Annals of Internal Medicine.

[5]  Ahmedin Jemal,et al.  Cancer Disparities by Race/Ethnicity and Socioeconomic Status , 2004, CA: a cancer journal for clinicians.

[6]  B. Powe,et al.  Cancer Fatalism: The State of the Science , 2003, Cancer nursing.

[7]  R. Czaja,et al.  The Determinants and Consequences of Information Seeking Among Cancer Patients , 2003, Journal of health communication.

[8]  G. Silvestri,et al.  Racial Differences Pertaining to a Belief about Lung Cancer Surgery: Results of a Multicenter Survey , 2003, Annals of Internal Medicine.

[9]  Adrienne Y. Stith,et al.  Unequal treatment: confronting racial and ethnic disparities in health care. , 2003 .

[10]  N. Powe,et al.  Race and Trust in the Health Care System , 2003, Public health reports.

[11]  R. Demicheli,et al.  Breast cancer screening: controversies and future directions , 2003, Current opinion in obstetrics & gynecology.

[12]  Only Ten Commandments , 2002, BMJ : British Medical Journal.

[13]  P. Ubel.  Is Information Always a Good Thing , 2002 .

[14]  P. Ubel.  Is Information Always a Good Thing?: Helping Patients Make “Good” Decisions , 2002, Medical care.

[15]  T. Davis,et al.  Health Literacy and Cancer Communication , 2002, CA: a cancer journal for clinicians.

[16]  D. Stewart,et al.  The views of ovarian cancer survivors on its cause, prevention, and recurrence. , 2001, Medscape women's health.

[17]  S. Quinn,et al.  African Americans' views on research and the Tuskegee Syphilis Study. , 2001, Social science & medicine.

[18]  D. E. Stewart,et al.  Attributions of cause and recurrence in long‐term breast cancer survivors , 2001, Psycho-oncology.

[19]  J. Ureda,et al.  Importance of Fatalism in Understanding Mammography Screening in Rural Elderly Women , 2001, Journal of women & aging.

[20]  R M Groves,et al.  Consequences of reducing nonresponse in a national telephone survey. , 2000, Public opinion quarterly.

[21]  R. Gross,et al.  Breast cancer: risk factors, screening, and prevention. , 2000, Seminars in oncology nursing.

[22]  C. Cleeland,et al.  Minority cancer patients and their providers , 2000, Cancer.

[23]  R. Morrison,et al.  "We don't carry that"--failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. , 2000, The New England journal of medicine.

[24]  M. Watson,et al.  Influence of psychological response on survival in breast cancer: a population-based cohort study , 1999, The Lancet.

[25]  C. Gatsonis,et al.  Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. , 1998, JAMA.

[26]  A. Seow,et al.  Fatalism Reconceptualized: A Concept to Predict Health Screening Behavior , 1998 .

[27]  C. Cleeland,et al.  Pain and Treatment of Pain in Minority Patients with Cancer: The Eastern Cooperative Oncology Group Minority Outpatient Pain Study , 1997, Annals of Internal Medicine.

[28]  V. Gamble.  Under the shadow of Tuskegee: African Americans and health care. , 1997, American journal of public health.

[29]  L. Chávez,et al.  The influence of fatalism on self-reported use of Papanicolaou smears. , 1997, American journal of preventive medicine.

[30]  M. O. Haynes.  Geriatric gynecologic care of minorities. , 1996, Clinical obstetrics and gynecology.

[31]  M. Conrad,et al.  Fatalism and Breast Cancer in Black Women , 1996, Annals of Internal Medicine.

[32]  M. Dignan,et al.  Skin cancer prevention and early detection practices in a sample of rural women. , 1996, Preventive medicine.

[33]  M. Levy.  Pharmacologic treatment of cancer pain. , 1996, The New England journal of medicine.

[34]  L. Degner,et al.  Information, support, and communication needs of women with a family history of breast cancer. , 1996, Cancer nursing.

[35]  John Lynch,et al.  Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study , 1995, Pain.

[36]  B. Powe,et al.  Cancer fatalism among elderly Caucasians and African Americans. , 1995, Oncology nursing forum.

[37]  S. Orsulic,et al.  Ovarian Cancer , 1993, British Journal of Cancer.

[38]  P. Vaeth.  Women's Knowledge About Breast Cancer: Dimensions of Knowledge and Scale Development , 1993, American journal of clinical oncology.

[39]  J. Haybittle,et al.  Psychological response to breast cancer and 15-year outcome , 1990, The Lancet.

[40]  David A. Kindig,et al.  Health literacy : a prescription to end confusion , 2004 .

[41]  M. Raber,et al.  Clinical Oncology in a Changing Healthcare Environment , 2003 .

[42]  J. Guidry,et al.  Barriers to breast cancer control for African‐American women , 2003, Cancer.

[43]  B. Smedley,et al.  The unequal burden of cancer : an assessment of NIH research and programs for ethnic minorities and the medically underserved , 1999 .

[44]  R. Oliver.  Testis cancer. , 1997, Current opinion in oncology.

[45]  R. Raven.  Principles of Surgical Oncology , 1977, Springer US.

[46]  R. Demicheli,et al.  Open Access Hypothesis: Induced Angiogenesis after Surgery in Premenopausal Node-positive Breast Cancer Patients Is a Major Underlying Reason Why Adjuvant Chemotherapy Works Particularly Well for Those Patients , 2022 .